Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
Aprea Therapeutics, Inc.
Next earnings ≈ Aug 12, 2026 · est. from filing cadence
Last earnings -2.2% on 2026-05-13
Conservative balance sheet (liabilities/equity 0.26x).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
Aprea Therapeutics, Inc. shows limited reported revenue, and -101.3% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
Sources: SEC EDGAR (CIK 0001781983, latest 10-Q filed 2026-05-13) · EODHD · rules-based read · as of 6/18/2026, 1:05:19 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$37.4M | -$113M | -$15.5M | -$14.3M | -$13.2M |
| Net income | -$37.1M | -$113M | -$14.3M | -$13.0M | -$12.6M |
| Diluted EPS | -$34.88 | -$67.99 | -$3.95 | -$2.35 | -$1.93 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
501 tracked peers · median
| 2026-06-16 | Grissinger Michael Director | Award | 3.13K | |
| 2026-06-16 | Gruia Gabriela Director | Award | 3.13K | |
| 2026-06-16 | Peters Richard Director | Award | 3.13K | |
| 2026-06-16 | HENNEMAN JOHN B III Director | Award | 3.13K | |
| 2026-06-16 | BIZZARI JEAN-PIERRE Director | Award | 3.13K | |
| 2026-06-16 | Duey Marc Director | Award | 3.13K | |
| 2026-06-16 | Pamukcu Rifat Director | Award | 3.13K | |
| 2026-06-16 | Seizinger Bernd R. Director | Award | 3.13K |